missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human FGFR2 alpha (IIIc) Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Marca: R&D Systems™ 712-FR-050
266.94 EUR hasta el 2024-12-16
Use el código promocional "21630" para aplicar la oferta.
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
The Recombinant Human FGF R2 alpha (IIIc) Fc Chimera Protein is derived from NS0. The Recombinant Human FGF R2 alpha (IIIc) Fc Chimera Protein has been validated for the following applications: Bioactivity.Especificaciones
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 66 kDa (monomer) | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 2263 | |
| FGFR2 alpha | |
| Mouse myeloma cell line,NS0-derived human FGF R2 alpha protein, (N-terminus) Human FGF R2 alpha (IIIc) (Arg22-Glu377) & (Leu27-Glu377) Accession &Num; P21802 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) | |
| Disulfide-linked homodimer | |
| Recombinant |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido